肝素
糖胺聚糖
生物化学
大肠杆菌
酶
化学
生物合成
葡萄糖醛酸
高尔基体
肝素辅因子Ⅱ
重组DNA
抗凝药
多糖
立体化学
抗凝血酶
基因
细胞
作者
Li Fu,Robert J. Linhardt
标识
DOI:10.1007/978-1-0716-1398-6_1
摘要
Heparin, a glycosaminoglycan-based anticoagulant drug, is prepared as an extract of animal tissues. Heparosan, an Escherichia coli (E. coli) K5 capsular polysaccharide with the structure →4)-β-D-glucuronic acid (1 → 4)-β-D-N-acetylglucosamine (1→, corresponds to the precursor backbone in the Golgi-based biosynthesis of heparin. Anticoagulant heparin is prepared in a one-pot synthesis using a chemically prepared derivative of heparosan called N-sulfoheparosan (NSH), recombinant Golgi enzymes expressed in E. coli, and the 3-phosphoadenosine-5-phosphosulfate (PAPS) cofactor.
科研通智能强力驱动
Strongly Powered by AbleSci AI